Ibrahim M. Sektioglu
Position: Postdoc, PhD
Phone: 22782319
Email:

Kreftforeningen

A. Education, Positions and Employment

2015 - 2016            Postdoctoral Fellow,

Dr. Andrea Schietinger’s Laboratory, Program of Immunology

Memorial Sloan Kettering Cancer Center, New York, NY

                 

2011 - 2015            PhD Graduate Studies, Division of Molecular Immunology

Cancer Research Center (DKFZ), Heidelberg, Germany

Ph.D thesis “Control of T cell infiltration and tumor rejection by regulatory T cells, basophils and macrophages

Thesis advisor: Professor Gunter J. Hammerling

 

2009-2011              Master Degree Studies of Molecular and Cellular Biology, Uppsala University, Uppsala, Sweden, and Division of Molecular Immunology, German Cancer Research Center, Heidelberg, Germany

M.Sc. thesis “Suppression of anti-tumor immune responses by Dickkopf-3

Thesis advisor: Professor Gunter J. Hammerling

 

2004-2009              Bachelor Degree Studies of Molecular Biology and Genetics

Bilkent University, Ankara, Turkey

2007: Internship, Barts Cancer Institute, London, United Kingdom

2008: Internship, University of Pennsylvania, Philadelphia, PA, USA

 

B. Honors and Awards

2004-2009              Full Scholarship Award, Bilkent University, Ankara, Turkey

 

2014                       Scholarship – The 3rd Network of Immunology Frontiers Winter (NIF) School on Advanced Immunology, Osaka, Japan

 

2015-2016              Parker Institute of Cancer Immunotherapy-Parker Scholar Award for Postdoctoral Research

 

C. Selected Abstracts and Oral Presentations

2013                       The 8th European Network of Immunology Institutes (ENII) Immunology Summer School, Sardinia, Italy (poster and talk)

 

2013                       The 43rd Annual Meeting of the German Society for Immunology, Mainz, Germany (poster)

 

2014                       The 3rd Network of Immunology Frontiers (NIF) Winter School on Advanced Immunology, Osaka, Japan (poster and talk)

 

D. Research interest and projects

Development and preclinical validation of genetically modified T cells for cancer immunotherapy

Development of personalized T cell therapies based on expression data derived from patients’ tumors

Strategic manipulation of the tumor microenvironment for efficient cancer immunotherapy

 

 

Author network for Ibrahim M. Sektioglu by COREMINE medical


Publications 2016

Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, Hämmerling GJ (2016)
Corrigendum: Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells
Nat Immunol, 17 (2), 214
PubMed 26784268

Sektioglu IM, Carretero R, Bender N, Bogdan C, Garbi N, Umansky V, Umansky L, Urban K, von Knebel-Döberitz M, Somasundaram V, Wink D, Beckhove P, Hämmerling GJ (2016)
Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection
Oncoimmunology, 5 (10), e1204506
PubMed 27853636

Sektioglu IM, Carretero R, Bulbuc N, Bald T, Tüting T, Rudensky AY, Hämmerling GJ (2016)
Basophils Promote Tumor Rejection via Chemotaxis and Infiltration of CD8+ T Cells
Cancer Res, 77 (2), 291-302
PubMed 27879269

Publications 2015

Carretero R, Sektioglu IM, Garbi N, Salgado OC, Beckhove P, Hämmerling GJ (2015)
Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells
Nat Immunol, 16 (6), 609-17
PubMed 25915731